B3GNT7
Basic information
Region (hg38): 2:231395671-231408799
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the B3GNT7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 26 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 3 | 0 |
Variants in B3GNT7
This is a list of pathogenic ClinVar variants found in the B3GNT7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-231397741-G-A | not specified | Likely benign (Aug 29, 2024) | ||
2-231397748-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
2-231397777-G-A | Uncertain significance (Oct 01, 2022) | |||
2-231397816-C-G | not specified | Uncertain significance (Mar 08, 2024) | ||
2-231397883-T-C | not specified | Uncertain significance (Mar 29, 2022) | ||
2-231397892-C-G | not specified | Uncertain significance (Feb 19, 2025) | ||
2-231397930-C-T | not specified | Uncertain significance (Aug 10, 2024) | ||
2-231398033-A-T | not specified | Uncertain significance (Jul 27, 2024) | ||
2-231398039-A-C | not specified | Uncertain significance (Aug 28, 2024) | ||
2-231398044-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
2-231398071-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
2-231398098-C-G | not specified | Uncertain significance (Jul 05, 2023) | ||
2-231398170-G-A | not specified | Uncertain significance (Sep 27, 2022) | ||
2-231398180-G-A | not specified | Uncertain significance (Aug 14, 2024) | ||
2-231398213-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
2-231398275-C-T | not specified | Uncertain significance (Jul 05, 2022) | ||
2-231398323-G-A | not specified | Uncertain significance (Jul 19, 2023) | ||
2-231398347-G-A | not specified | Uncertain significance (Oct 26, 2024) | ||
2-231398351-C-A | not specified | Uncertain significance (Aug 20, 2023) | ||
2-231398366-C-G | not specified | Uncertain significance (Jun 16, 2023) | ||
2-231398379-C-G | not specified | Uncertain significance (Jun 13, 2023) | ||
2-231398389-A-G | not specified | Uncertain significance (May 23, 2023) | ||
2-231398567-A-T | not specified | Uncertain significance (Jan 15, 2025) | ||
2-231398587-G-A | not specified | Likely benign (Jun 07, 2023) | ||
2-231398620-G-A | not specified | Uncertain significance (Sep 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
B3GNT7 | protein_coding | protein_coding | ENST00000287590 | 2 | 5622 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.706 | 0.293 | 124620 | 0 | 15 | 124635 | 0.0000602 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.19 | 221 | 277 | 0.799 | 0.0000195 | 2587 |
Missense in Polyphen | 65 | 111.86 | 0.58108 | 1074 | ||
Synonymous | -0.401 | 141 | 135 | 1.04 | 0.0000104 | 850 |
Loss of Function | 2.79 | 2 | 12.7 | 0.157 | 6.24e-7 | 128 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000249 | 0.000247 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000465 | 0.0000464 |
European (Non-Finnish) | 0.0000357 | 0.0000354 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000331 | 0.0000327 |
Other | 0.000520 | 0.000495 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in keratane sulfate biosynthesis. Transfers N-acetylgalactosamine on to keratan sulfate-related glycans. May play a role in preventing cells from migrating out of the original tissues and invading surrounding tissues. {ECO:0000269|PubMed:12061784}.;
- Pathway
- Glycosaminoglycan biosynthesis - keratan sulfate - Homo sapiens (human);Metabolism of carbohydrates;Keratan sulfate biosynthesis;Keratan sulfate/keratin metabolism;Glycosaminoglycan metabolism;Post-translational protein modification;Metabolism of proteins;Metabolism;O-linked glycosylation of mucins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.354
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.34
Haploinsufficiency Scores
- pHI
- 0.432
- hipred
- Y
- hipred_score
- 0.684
- ghis
- 0.393
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.220
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- B3gnt7
- Phenotype
- vision/eye phenotype; immune system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein glycosylation;O-glycan processing;keratan sulfate biosynthetic process;poly-N-acetyllactosamine biosynthetic process
- Cellular component
- Golgi membrane;endoplasmic reticulum;Golgi apparatus;integral component of membrane
- Molecular function
- acetylgalactosaminyltransferase activity;UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity;N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity